Team:SDU-Denmark/Tour71
You really should try our interactive wiki tour instead!
But if you are looking for a specific page - you are in the right place.
Medical aspects
Although there is no doubt that peptide aptamers are potential tivals of traditional antibodies in medicine and therapy, some challenges have to accomodated before they can be implemented clinically.
Size of the peptide
The bigger molecule the larger risk of immunogenicity. To avoid an respons from the human immune system it is important that the peptide is as small as possible. If the immune system develops immunization against the peptide aptamer it will not have any function at all.
Effector mechanism
Traditional antibodies have a Fab region, that bind to microbes of which they have specificity. Activation of the immune respons is conducted through their Fc region that interacts with Fc receptors on cell surfaces of lymphocytes and other effector cells of the immune system.Half-life
Next chapter
Next chapter
Dig deeper
End of tour
Want more? Go to iGEM.org!
If you want to learn more about Synthetic Biology you should visit iGEM's homepage, which contains loads on the subject. You can even visit other teams' wikis and take a look at what they accomplished. Or maybe join a team yourself?